{"abdominal distension": 2.82, "abdominal pain": 2.45, "gait inability": 2.24, "hot flush": 10.57, "incorrect dose administered": 2.14, "incorrect route of product administration": 6.7, "injection site abscess": 80.5, "injection site cellulitis": 106.55, "injection site discomfort": 12.97, "injection site erythema": 21.7, "injection site haematoma": 6.44, "injection site haemorrhage": 7.22, "injection site induration": 73.3, "injection site infection": 50.44, "injection site inflammation": 6.23, "injection site mass": 98.33, "injection site nodule": 166.51, "injection site oedema": 23.29, "injection site pain": 9.23, "injection site pruritus": 5.2, "injection site rash": 12.17, "injection site reaction": 11.53, "injection site swelling": 9.84, "injection site urticaria": 13.07, "injection site warmth": 4.33, "pollakiuria": 2.9, "product administered at inappropriate site": 58.43, "prostatic specific antigen increased": 17.46, "wrong technique in product usage process": 5.2}